EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

High‐density lipoprotein in diabetes: Structural and functional relevance

David Tak Wai Lui, Kathryn Choon Beng Tan iD

Journal of Diabetes Investigation · 2024-07 · 15 (7) · 805-816

DOI: 10.1111/jdi.14172 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Diabetes Investigation, online erschienen am 28.02.2024. Verfasst von David Tak Wai Lui und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Lipoproteins, HDL. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Low levels of high‐density lipoprotein‐cholesterol (HDL‐C) is considered a major cardiovascular risk factor. However, recent studies have suggested a more U‐shaped association between HDL‐C and cardiovascular disease. It has been shown that the cardioprotective effect of HDL is related to the functions of HDL particles rather than their cholesterol content. HDL particles are highly heterogeneous and have multiple functions relevant to cardiometabolic conditions including cholesterol efflux capacity, anti‐oxidative, anti‐inflammatory, and vasoactive properties. There are quantitative and qualitative changes in HDL as well as functional abnormalities in both type 1 and type 2 diabetes. Non‐enzymatic glycation, carbamylation, oxidative stress, and systemic inflammation can modify the HDL composition and therefore the functions, especially in situations of poor glycemic control. Studies of HDL proteomics and lipidomics have provided further insights into the structure–function relationship of HDL in diabetes. Interestingly, HDL also has a pleiotropic anti‐diabetic effect, improving glycemic control through improvement in insulin sensitivity and β‐cell function. Given the important role of HDL in cardiometabolic health, HDL‐based therapeutics are being developed to enhance HDL functions rather than to increase HDL‐C levels. Among these, recombinant HDL and small synthetic apolipoprotein A‐I mimetic peptides may hold promise for preventing and treating diabetes and cardiovascular disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipoproteins, HDLHumansCardiovascular DiseasesDiabetes Mellitus, Type 2AnimalsDiabetes Mellitus, Type 1Diabetes Mellitus

Stichwörter der Autor:innen

Anti‐inflammatory activityAnti‐oxidative activityCholesterol efflux

Substanzen

Lipoproteins, HDL

Autor:innen und Institutionen

  • Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.

ORCID-Profile: Kathryn Choon Beng Tan

Zitieren

APA

Lui, D. T. W., & Tan, K. C. B. (2024). High‐density lipoprotein in diabetes: Structural and functional relevance. Journal of Diabetes Investigation, 15(7), 805-816. https://doi.org/10.1111/jdi.14172

Vancouver

Lui DTW, Tan KCB. High‐density lipoprotein in diabetes: Structural and functional relevance. Journal of Diabetes Investigation. 2024;15(7):805-816. doi:10.1111/jdi.14172

BibTeX
@article{Lui2024,
  author = {Lui, David Tak Wai and Tan, Kathryn Choon Beng},
  title = {High‐density lipoprotein in diabetes: Structural and functional relevance},
  journal = {Journal of Diabetes Investigation},
  year = {2024},
  volume = {15},
  number = {7},
  pages = {805--816},
  doi = {10.1111/jdi.14172}
}
Kostenlos starten →